Skip to main content

Table 1 Basic characteristics of patients with post-stroke epilepsy in the four ASM groups

From: Effects of long-term anti-seizure medication monotherapy on all-cause death in patients with post-stroke epilepsy: a nationwide population-based study in Taiwan

 

Phenytoin

(n = 3917)

Valproic acid

(n = 1623)

Carbamazepine

(n = 457)

New ASM (n = 965)

Age of ASM use, y, mean(SD)

67.6 (14.0)

68.7 (14.4)

66.3 (13.2)

66.1 (13.7)

Hemorrhagic stroke, n (%)

1420 (36.3 %)

456 (28.1 %)

169 (37.0 %)

267 (27.7 %)

Male, n (%)

2525 (64.5 %)

998 (61.5 %)

248 (54.3 %)

587 (60.8 %)

Hypertension, n (%)

3558 (90.8 %)

1468 (90.5 %)

422 (92.3 %)

863 (89.4 %)

Diabetic mellitus, n (%)

1609 (41.1 %)

668 (41.2 %)

194 (42.5 %)

420 (43.5 %)

Hyperlipidemia, n (%)

1608 (41.1 %)

761 (46.9 %)

205 (44.9 %)

534 (55.3 %)

Ischemic heart disease, n (%)

1780 (45.4 %)

779 (48.0 %)

183 (40.0 %)

430 (44.6 %)

Heart failure, n (%)

524 (13.4 %)

228 (14.1 %)

45 (9.9 %)

97 (10.1 %)

Atrial fibrillation, n (%)

767 (19.6 %)

355 (21.9 %)

40 (8.8 %)

166 (17.2 %)

Prior stroke, n (%)

1125 (28.7 %)

499 (30.8 %)

120 (26.3 %)

269 (27.9 %)

Chronic kidney disease, n (%)

345 (8.8 %)

143 (8.8 %)

41 (9.0 %)

110 (11.4 %)

Peripheral vascular disease, n (%)

20 (4.4 %)

123 (3.1 %)

72 (4.4 %)

46 (4.8 %)

Mood disorder, n (%)

352 (9.0 %)

210 (12.9 %)

50 (10.9 %)

99 (10.3 %)

Dementia, n (%)

719 (18.4 %)

354 (21.8 %)

60 (13.1 %)

115 (11.9 %)

Migraine, n (%)

128 (3.3 %)

63 (3.9 %)

24 (5.3 %)

54 (5.6 %)

Stroke severity index

    

Mild, n (%)

515 (13.2 %)

312 (19.2 %)

74 (16.2 %)

188 (19.5 %)

Moderate, n (%)

2573 (65.7 %)

1014 (62.5 %)

348 (76.2 %)

632 (65.5 %)

Severe, n (%)

829 (21.2 %)

297 (18.3 %)

35 (7.7 %)

145 (15.0 %)

Concomitant medications

    

Anticoagulants, n (%)

241 (6.2 %)

163 (10.0 %)

16 (3.5 %)

95 (9.8 %)

Antidepressants, n (%)

545 (13.9 %)

305 (18.8 %)

120 (26.3 %)

230 (23.8 %)

Antiplatelet, n (%)

1900 (48.5 %)

835 (51.5 %)

242 (53.0 %)

513 (53.2 %)

Statins, n (%)

500 (12.8 %)

249 (15.3 %)

71 (15.5 %)

213 (22.1 %)

Interval from index stroke to index date of ASM use, years, mean(SD)

1.5 (1.7)

1.6 (1.8)

1.0 (1.1)

1.7 (2.0)

  1. Abbreviations: ASM anti-seizure medication; SD standard deviation